Elevance Health (ELV) Stock Forecast & Price Target
Score
Elevance Health Inc. price target
| ELV | |
|---|---|
| Low | $395.00 |
| Average | $466.69 |
| High | $523.00 |
| Upside vs current price | +8.6% |
The average target of $466.69 is +8.6% versus the current ELV price of $429.67.
Elevance Health Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 3 |
| Buy | 12 |
| Hold | 7 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
22 analysts cover ELV.
Elevance Health Inc. EPS and revenue estimates
ELV shows the next fiscal years with at least three analysts: 2026 EPS $29.05, 2027 EPS $30.25. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $29.05 | $200.07B |
| 2027 | $30.25 | $205.03B |
Is Elevance Health Inc. a buy or sell?
Of the 22 analysts covering Elevance Health Inc., 15 rate it a buy (3 strong buy and 12 buy), 7 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The ELV consensus label is Buy, beside 15 buy-side ratings and 0 sell-side ratings.
The average target of $466.69 implies +8.6% versus the current price of $429.67.
Those 22 ratings on ELV are a headcount, and the label on file is Buy.
Reading the Elevance Health Inc. forecast
The ELV target band runs from $395.00 to $523.00. The average inside that band is $466.69.
Set next to the $429.67 ELV quote, that average is +8.6%.
Ratings on the Elevance Health Inc. cluster: 15 of 22 analysts are on the buy side, 7 are at hold, and 0 are on the sell side, and the published consensus is Buy.
ELV targets have not moved much: $473.10 recently, $473.10 across the quarter.
22 analysts publish on ELV, so one note does not swing the average by itself.
Elevance Health Inc. forecast questions
What is the ELV price target?
The published range for ELV is $395.00 to $523.00, with an average of $466.69. That average is +8.6% versus the current price of $429.67.
Is Elevance Health Inc. a buy or sell?
Of the 22 analysts covering Elevance Health Inc., 15 rate it a buy, 7 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the ELV headcount is 15 buy, 7 hold, and 0 sell.
What is the EPS estimate for Elevance Health Inc.?
Analyst EPS estimates for Elevance Health Inc.: 2026 $29.05, 2027 $30.25.
What is the revenue estimate for Elevance Health Inc.?
Analyst revenue estimates for Elevance Health Inc.: 2026 $200.07B, 2027 $205.03B.
How many analysts cover ELV?
22 analysts cover ELV. Their consensus on ELV is Buy, across those 22.